4 weeks Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $58.00 at Cantor FitzgeraldMarketBeat
Cantor Fitzgerald raised their price objective on Harmony Biosciences from $51.00 to $58.00 and gave the company an “overweight” rating in a research note on Wednesday.
X